Epithalon dosage protocol

What the compound is

Epithalon, also known as Epitalon or Epithalone, is a tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). It was synthesized based on the amino acid composition of Epithalamin, a natural extract from the bovine pineal gland (PMID 40141333). It is described as a synthetic short peptide (PMID 35413689) and a naturally occurring tetrapeptide (PMID 40908429). Epithalon is a specific tetrapeptide for the pineal gland and retina, possibly reflecting their common embryonal origin (PMID 12374906).

How it is thought to work

Epithalon is thought to exert geroprotective (aging-protective) and neuroendocrine effects through antioxidant, neuro-protective, and antimutagenic mechanisms (PMID 40141333). It targets circadian and mitochondrial regulators (PMID 41490200). Studies indicate it can directly influence melatonin synthesis, alter mRNA levels of interleukin-2, modulate the mitogenic activity of murine thymocytes, and enhance the activity of various enzymes, including AChE, BuChE, and telomerase (PMID 40141333). Its effects are believed to involve transcription factors that may be specific for the pineal gland and retina in mammals (PMID 12096440). Epithalon can extend telomere length in normal mammalian cells (PMID 40908429) and reduces intracellular reactive oxygen species (ROS) in mouse oocytes (PMID 35413689) and human retinal cells (PMID 40493162).

What laboratory and animal studies report

In human breast cancer cell lines and normal epithelial and fibroblast cells, Epitalon caused dose-dependent telomere length extension. This occurred through upregulation of hTERT mRNA expression and telomerase enzyme activity in normal cells, and through ALT (Alternative Lengthening of Telomeres) activation in cancer cells (PMID 40908429). In an in vitro model of diabetic retinopathy, Epitalon restored impaired wound healing in high glucose-injured human retinal pigment epithelial cells (ARPE-19) by inhibiting hyperglycemia-induced epithelial-mesenchymal transition (EMT) and fibrosis. It also decreased intracellular reactive oxygen species (ROS) and increased antioxidant gene expression in these cells (PMID 40493162). In mouse oocytes, Epitalon reduced intracellular reactive oxygen species, decreased spindle defects and abnormal cortical granule distribution during aging, and increased mitochondrial membrane potential and DNA copy number of mitochondria, thereby decreasing apoptosis (PMID 35413689). In rats and mice, Epithalamin (the extract Epitalon is based on) increased melatonin production, improved immunological parameters, produced anticarcinogenic effects, stimulated antioxidant defenses, and restored reproductive function in old rats. It also increased the lifespan in rats, mice, and fruit flies (PMID 12374906). Epitalon, specifically, increased the lifespan of mice and fruit flies and restored the circadian rhythms of melatonin and cortisol production in old rhesus monkeys (PMID 12374906, PMID 12096440). It also postponed vision loss in Campbell rats with hereditary pigmental dystrophy (PMID 12096440).

Human evidence so far

Some effects of Epithalamin (the extract Epitalon is based on) have been reproduced in clinical trials, which have demonstrated geroprotector activity in humans (PMID 12374906). However, despite promising preclinical studies, there is a current lack of clinical trials for therapeutic peptides like Epitalon in orthopaedics (PMID 41490200). While non-approved peptides like Epitalon show promising preclinical and limited clinical evidence, they lack long-term safety data and systematic validation (PMID 42021992).

Open questions and limitations

It remains uncertain whether the identified mechanisms of action are the sole ways Epitalon works (PMID 40141333). While there is considerable research on its biological and pharmacodynamic characteristics, the quantity of physico-chemical and structural investigations remains limited (PMID 40141333). Significant knowledge gaps include optimal dosing regimens, combination therapy effects, and biomarkers for monitoring efficacy (PMID 42021992). More mechanistic investigations are needed to confirm Epitalon's benefits and safety, and developing ophthalmic forms may enhance its delivery for retinal conditions (PMID 40493162). Rigorous validation through well-designed clinical trials is required to establish safety and efficacy for healthspan extension (PMID 42021992).

Key terms explained

**Tetrapeptide:** A peptide consisting of four amino acid residues (PMID 40141333).

**Geroprotective:** Protecting against or slowing down the aging process (PMID 40141333).

**Telomere length:** The length of protective caps at the ends of chromosomes, linked to aging-related diseases and considered a biomarker of aging (PMID 40908429).

**Telomerase:** An enzyme that helps maintain or extend telomere length (PMID 40908429).

**Alternative Lengthening of Telomeres (ALT):** A telomerase-independent mechanism for maintaining telomere length, typically observed in certain cancer cells (PMID 40908429).

**Reactive Oxygen Species (ROS):** Chemically reactive chemical species containing oxygen, which can cause cellular damage (PMID 40493162, PMID 35413689).

**Epithelial-Mesenchymal Transition (EMT):** A process where epithelial cells lose their cell polarity and cell-cell adhesion, and gain migratory and invasive properties (PMID 40493162).